发明名称 MEDICINAL AGENTS APPLIED FOR CONTINUOUS POST ACUTE STROKE THERAPY
摘要 FIELD: medicine. ^ SUBSTANCE: offered medicinal agents are applied to prevent post acute stroke infections. As such mezlocylline, moxifloxacine, cy-lastatine, imipenem and sulbactam, or gamma-interferon is offered. At that preventive therapy starts in 12-72 hours after stroke. Immunomodulating properties of propranolol are discovered for application to prevent infectious starting before 12 hours after stroke, specifically after stroke. ^ EFFECT: invention enables to prevent serious bacterial infectious and increase post-stroke survival rate. ^ 8 cl, 4 ex, 10 dwg
申请公布号 RU2327454(C2) 申请公布日期 2008.06.27
申请号 RU20040129591 申请日期 2003.03.05
申请人 SHARITE - UNIVERZITETSMEDITSIN BERLIN 发明人 MAJZEL' ANDREAS;PRASS KONSTANTIN;MAJZEL' KRISTIAN;KHALLE EHL'KE;DIRNAGL' UL'RIKH;FOL'K KHANS DITER
分类号 A61K31/00;A61K31/198;A61K31/138;A61K31/407;A61K31/43;A61K31/431;A61K31/437;A61K31/4709;A61K35/76;A61K38/19;A61K38/21;A61K45/00;A61K45/06;A61P9/10;A61P31/00;A61P37/00 主分类号 A61K31/00
代理机构 代理人
主权项
地址